Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lola Zerbib

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Annual Review of Genomics and Human Genetics|February 5, 2024
<i>PIK3CA</i>-Related Disorders: From Disease Mechanism to Evidence-Based TreatmentsGabriel M Morin, Lola Zerbib, Sophie Kaltenbach, et al.
The New England Journal of Medicine|July 17, 2024
Sotorasib for Vascular Malformations Associated with <i>KRAS</i> G12C MutationAntoine Fraissenon, Charles Bayard, Gabriel Morin, et al.
Science Translational Medicine|October 6, 2021
Alpelisib administration reduced lymphatic malformations in a mouse model and in patientsFlorence Delestre, Quitterie Venot, Charles Bayard, et al.
The Journal of Experimental Medicine|September 15, 2023
Hemifacial myohyperplasia is due to somatic muscular PIK3CA gain-of-function mutations and responds to pharmacological inhibitionCharles Bayard, Eleonora Segna, Maxime Taverne, et al.
Signal Transduction and Targeted Therapy|June 16, 2024
Targeted therapy for capillary-venous malformationsLola Zerbib, Sophia Ladraa, Antoine Fraissenon, et al.
Science Advances|December 9, 2022
PIK3CA gain-of-function mutation in adipose tissue induces metabolic reprogramming with Warburg-like effect and severe endocrine disruptionSophia Ladraa, Lola Zerbib, Charles Bayard, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Annual Review of Genomics and Human Genetics|February 5, 2024
<i>PIK3CA</i>-Related Disorders: From Disease Mechanism to Evidence-Based TreatmentsGabriel M Morin, Lola Zerbib, Sophie Kaltenbach, et al.
The New England Journal of Medicine|July 17, 2024
Sotorasib for Vascular Malformations Associated with <i>KRAS</i> G12C MutationAntoine Fraissenon, Charles Bayard, Gabriel Morin, et al.
Science Translational Medicine|October 6, 2021
Alpelisib administration reduced lymphatic malformations in a mouse model and in patientsFlorence Delestre, Quitterie Venot, Charles Bayard, et al.
The Journal of Experimental Medicine|September 15, 2023
Hemifacial myohyperplasia is due to somatic muscular PIK3CA gain-of-function mutations and responds to pharmacological inhibitionCharles Bayard, Eleonora Segna, Maxime Taverne, et al.
Signal Transduction and Targeted Therapy|June 16, 2024
Targeted therapy for capillary-venous malformationsLola Zerbib, Sophia Ladraa, Antoine Fraissenon, et al.
Science Advances|December 9, 2022
PIK3CA gain-of-function mutation in adipose tissue induces metabolic reprogramming with Warburg-like effect and severe endocrine disruptionSophia Ladraa, Lola Zerbib, Charles Bayard, et al.
Pageof 1